Pfizer to transfer its Upjohn business to Mylan

For consideration of Rs 180.48 cr

Pfizer has entered into a business transfer agreement (BTA) with Mylan Pharmaceuticals (Mylan) to transfer certain primarily off-patent branded and generic established medicines business (Upjohn Business) as a going concern to Mylan for a consideration of Rs 180.48 crore.

The Upjohn Business comprises of six brands which includes Lyrica, Viagra, Celebrex, Amlogard, Daxid and Dilantin. These along with related business assets and liabilities will transition to Mylan.

Powered by Capital Market - Live News